Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/19445
Title
Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis.
Author(s)
Date issued
2024-03-28
Citation
Nanoscale. 2024 Mar 28;16(13):6477-6487.
Language
Inglés
Document type
journal article
Abstract
Atherosclerosis, a leading cause of cardiovascular diseases requires approaches to enhance disease monitoring and treatment. Nanoparticles offer promising potential in this area by being customisable to target components or molecular processes within plaques, while carrying diagnostic and therapeutic agents. However, the number of biomarkers available to target this disease is limited. This study investigated the use of sphingomyelin-based nanomicelles triggered by sphingomyelinase (SMase) in atherosclerotic plaques. Accumulation of iron oxide-based nanomicelles in the plaque was demonstrated by fluorescence, MR imaging and electron microscopy. These findings demonstrate the possibility of utilising SMase as a mechanism to retain nanoprobes within plaques, thus opening up possibilities for future therapeutic interventions.
MESH
Atherosclerosis | Plaque, Atherosclerotic | Nanoparticles | Humans | Sphingomyelin Phosphodiesterase | Magnetic Resonance Imaging
Online version
DOI
Collections